List view / Grid view
8 July 2015 | By Victoria White
Sanofi is to extend its collaboration with Medicines for Malaria Venture (MMV) to jointly develop a new single, fixed-dose combination therapy for malaria...
21 May 2015 | By Victoria White
Despite optimism surrounding new dengue and a malaria vaccines, vaccination alone is not a long-term solution for combatting these diseases, says GlobalData...
24 April 2015 | By Victoria White
Phase III trial results of the RTS,S vaccine candidate show that it helped protect children from clinical malaria for at least 3 years after vaccination...
12 November 2014 | By Novartis
Novartis announced that, through Power of One, enough funds have been raised to deliver three million antimalarial treatments for children in Zambia...
3 September 2014 | By Andrew Lloyd & Associates
CleveXel Pharma announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding the development of two new products...
31 July 2014 | By Novartis
Novartis published clinical trial results in the New England Journal of Medicine showing that KAE609 (cipargamin), a novel and potent antimalarial drug candidate...
28 April 2014 | By GlaxoSmithKline
GlaxoSmithKline and Medicines for Malaria Venture announced the start of a phase III global programme to evaluate the efficacy and safety of tafenoquine...
7 April 2014 | By Novartis
Novartis announced that two million treatments of its pediatric antimalarial are arriving in Zambia thanks to the ongoing efforts of the company in collaboration with Malaria No More's Power of One campaign...
28 November 2013 | By Novartis
Novartis scientists have discovered a new drug target for treating malaria...
8 October 2013 | By GlaxoSmithKline
These latest results demonstrated that over 18 months of follow-up, RTS,S was shown to almost halve the number of malaria cases...
25 April 2013 | By Sanofi
More than 200 million treatments of ASAQ Winthrop have been distributed in Africa...
25 April 2013 | By Novartis
"We believe that this innovative campaign will help speed malaria elimination..."
11 April 2013 | By Sanofi
A pivotal milestone in the fight against malaria...
9 November 2012 | By GlaxoSmithKline
Results from ongoing Phase III clinical trial announced...
29 November 2011 | By Sanofi
Sanofi organizes the 10th Edition of the Pan-African Conference against Malaria with representatives of 34 African Countries...
